Article Details

Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL

Retrieved on: 2024-01-22 17:36:30

Tags for this article:

Click the tags to see associated articles and topics

Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL. View article details on hiswai:

Excerpt

Although ibrutinib adds to the cost of treatment, its benefits over the long term justify the cost, investigators found.

Article found on: www.ajmc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up